Table 5 Drug classes being involved in rPDDI between antineoplastic agents/supportive care medication and the long-term medication; n = 128
Drug class (ATC code level 2) | Number of detected interactions | Interaction propensity |
|---|---|---|
Corticosteroids for systemic use (H02) | 13 | 0.12 |
Diuretics (C03) | 10 | 0.16 |
Antimetabolites (L01B) | 9 | 0.30 |
Antithrombotic agents (B01) | 8 | 0.11 |
Agents acting on the renin-angiotensin system (C09) | 8 | 0.12 |
Antiemetics and antinauseants (A04) | 8 | 0.07 |
Antigout agents (M04) | 8 | 0.13 |
Alkylating agents (L01A) | 6 | 0.13 |
Drugs used in diabetes (A10) | 6 | 0.21 |
Antibiotics (J01) | 6 | 0.86 |
Others | 18 | - |